Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “PD-1 Antibodies”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)UnknownNCT03944980
What this trial is testing

Study of Chemotherapy Combination With Autologous Cell Immunotherapy in the Advanced Lung Cancer

Who this might be right for
IIIB/IIIC/IV Lung Cancer
Tianjin Medical University Cancer Institute and Hospital 146
Testing effectiveness (Phase 2)Looking for participantsNCT06943820
What this trial is testing

AK129 Combination Therapy for Advanced Solid Tumors

Who this might be right for
Non-small Cell Lung Cancer Stage IIIB/IVHead and Neck Squamous Cell Carcinoma (HNSCC)Colorectal Adenocarcinoma+1 more
Akeso 230
Testing effectiveness (Phase 2)UnknownNCT03250962
What this trial is testing

SHR-1210 Alone or in Combination With Decitabine in Relapsed or Refractory Hodgkin Lymphoma

Who this might be right for
Hodgkin Lymphoma
Chinese PLA General Hospital 280
Very early researchActive Not RecruitingNCT04656535
What this trial is testing

AB154 Combined With AB122 for Recurrent Glioblastoma

Who this might be right for
Glioblastoma
Yale University 46
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07641010
What this trial is testing

PD-1 Antibody and JAK1 Inhibitor for Newly Diagnosed Pediatric Hodgikin's Lympoma

Who this might be right for
Hodgkin Lymphoma
Shanghai Jiao Tong University School of Medicine 112
Testing effectiveness (Phase 2)Active Not RecruitingNCT04652076
What this trial is testing

GYNecological Cancers Treated with NETrin MAbs in Combination with Chemotherapy and /or Pembrolizumab

Who this might be right for
Endometrial CarcinomaCervix Carcinoma
NETRIS Pharma 240
Early research (Phase 1)Looking for participantsNCT06826768
What this trial is testing

A Ph Ib Study of REGN5678 Plus Cemiplimab in Patients With mCRPC

Who this might be right for
Prostate Cancer
M.D. Anderson Cancer Center 60
Testing effectiveness (Phase 2)Active Not RecruitingNCT06992024
What this trial is testing

Electroacupuncture Combined With Paclitaxel Protein-bound and PD-1 Antibody for Second-line Treatment of HER2 Negative, pMMR/MSS Advanced Gastric Cancer

Who this might be right for
Electroacupuncture Combined With Paclitaxel Protein-bound and PD-1 Antibody for Second-line Treatment of HER2 Negative, pMMR/MSS Advanced Gastric Cancer
Second Affiliated Hospital, Zhejiang University, School of Medicine 25
Testing effectiveness (Phase 2)UnknownNCT03839550
What this trial is testing

Combine Apatinib Mesylate With PD-1 Antibody SHR-1210 for HCC With High Risk of Recurrence After Radical Resection

Who this might be right for
Hepatocellular Carcinoma
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 200
Testing effectiveness (Phase 2)WithdrawnNCT02586610
What this trial is testing

Trial of Chemoradiation and Pembrolizumab in Patients With Rectal Cancer

Who this might be right for
Rectal CancerRectal Neoplasm
Osama Rahma, MD
Testing effectiveness (Phase 2)Study completedNCT04188860
What this trial is testing

Immunotherapy for Recurrent Cervical Cancer Refractory to Platinum-based Chemotherapy

Who this might be right for
Recurrent Cervical CarcinomaPersistent Advanced Cervical CarcinomaChemotherapy+2 more
Lei Li 34
Early research (Phase 1)Looking for participantsNCT06022029
What this trial is testing

A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas.

Who this might be right for
Triple Negative Breast CancerDiffuse Large B Cell LymphomaFollicular Lymphoma+11 more
OncoNano Medicine, Inc. 168
Testing effectiveness (Phase 2)WithdrawnNCT03803254
What this trial is testing

HAIC Plus Lenvatinib and PD-1 Antibody Versus HAIC Plus Lenvatinib for Advanced HCC

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University
Testing effectiveness (Phase 2)Active Not RecruitingNCT04931654
What this trial is testing

Assess the Safety and Efficacy of AZD7789 in Participants With Advanced or Metastatic Solid Cancer

Who this might be right for
Carcinoma, Non-Small-Cell LungGastric CancerGastroesophageal Junction Cancer
AstraZeneca 136
Not applicableLooking for participantsNCT07100405
What this trial is testing

TACE Combined With Anti-PD-1 Antibody in Patients With Advanced Hepatocellular Carcinoma: Study on Efficacy and Immune Microenvironment

Who this might be right for
Hepatocellular Carcinoma
Fudan University 50
Testing effectiveness (Phase 2)Ended earlyNCT03379259
What this trial is testing

Study of BGB-A333 Alone and in Combination With Tislelizumab in Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
BeiGene 39
Testing effectiveness (Phase 2)Looking for participantsNCT07315854
What this trial is testing

Iparomlimab and Tuvonralimab (QL1706) Combined With Chemotherapy for Previously Untreated Advanced or Metastatic Gastric or Gastroesophageal Junction Cancer

Who this might be right for
Gastric Cancer (GC)Gastroesophageal Junction CancerAdvanced Gastric Cancer+1 more
Beijing Friendship Hospital 32
Testing effectiveness (Phase 2)Looking for participantsNCT06482801
What this trial is testing

Checkpoint Inhibitor Combinations Therapy as First Line for HCC Via IT

Who this might be right for
Liver CancerAntibody
Second Affiliated Hospital of Guangzhou Medical University 90
Large-scale testing (Phase 3)Active Not RecruitingNCT05785767
What this trial is testing

Learn if a Combination of Fianlimab and Cemiplimab Versus Cemiplimab Alone is More Effective for Adult Participants With Advanced Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Advanced Non-Small Cell Lung Cancer
Regeneron Pharmaceuticals 149
Testing effectiveness (Phase 2)Study completedNCT02902042
What this trial is testing

Encorafenib + Binimetinib + Pembrolizumab in Patients With Unresectable or Metastatic BRAF V600 Mutant Melanoma

Who this might be right for
Malignant Melanoma
Prof. Dr. med. Dirk Schadendorf 16
Next Page